MXQ-10851-23086
1 vaccination
1 coded response
1 check-in
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 378 / TN
- Registered
- 2020-12-20
- Relationship
- Self
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-20
Registered in v-safe
-
2020-12-20
Survey response — days 1–6 daily, dose 1MedDRA: Occupational therapy, Peripheral swelling — Feeling: Fair · Site: Pain · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Underarm swelling · Healthcare visit (other): Occupational healthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-20
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2020-12-22
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Underarm swelling
Healthcare visit (other): Occupational health
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Occupational therapy | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | ○ | ○ | ○ |
| SRO | Oedema peripheral | ○ | ○ | ○ |
| SRO | Peripheral swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release